Salud financiera de hoja de balance de Solara Active Pharma Sciences
Salud financiera controles de criterios 2/6
Solara Active Pharma Sciences tiene unos fondos propios totales de ₹14.7B y una deuda total de ₹9.8B, lo que sitúa su ratio deuda/fondos propios en 67.2%. Sus activos y pasivos totales son ₹28.8B y ₹14.1B respectivamente.
Información clave
67.2%
Ratio deuda-patrimonio
₹9.85b
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | ₹64.60m |
| Patrimonio | ₹14.66b |
| Total pasivo | ₹14.09b |
| Activos totales | ₹28.75b |
Actualizaciones recientes sobre salud financiera
Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?
Mar 13
Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?
Sep 30Solara Active Pharma Sciences (NSE:SOLARA) Is Making Moderate Use Of Debt
Jun 19Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?
May 31Recent updates
Investors Still Aren't Entirely Convinced By Solara Active Pharma Sciences Limited's (NSE:SOLARA) Revenues Despite 28% Price Jump
Apr 19Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?
Mar 13Even With A 26% Surge, Cautious Investors Are Not Rewarding Solara Active Pharma Sciences Limited's (NSE:SOLARA) Performance Completely
Feb 23Further Upside For Solara Active Pharma Sciences Limited (NSE:SOLARA) Shares Could Introduce Price Risks After 25% Bounce
Jan 04Solara Active Pharma Sciences Limited's (NSE:SOLARA) Intrinsic Value Is Potentially 81% Above Its Share Price
May 12Estimating The Intrinsic Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)
Nov 08Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?
Sep 30Are Investors Undervaluing Solara Active Pharma Sciences Limited (NSE:SOLARA) By 22%?
Aug 03Solara Active Pharma Sciences (NSE:SOLARA) Is Making Moderate Use Of Debt
Jun 19Newsflash: Solara Active Pharma Sciences Limited (NSE:SOLARA) Analysts Have Been Trimming Their Revenue Forecasts
Feb 17A Look At The Fair Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)
Dec 21With EPS Growth And More, Solara Active Pharma Sciences (NSE:SOLARA) Is Interesting
Oct 28Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?
May 31Need To Know: Analysts Are Much More Bullish On Solara Active Pharma Sciences Limited (NSE:SOLARA) Revenues
May 11Análisis de la situación financiera
Pasivos a corto plazo: SOLARALos activos a corto plazo (₹11.9B) de la empresa superan a sus pasivos a corto plazo (₹11.7B).
Pasivo a largo plazo: SOLARALos activos a corto plazo (₹11.9B) superan a sus pasivos a largo plazo (₹2.4B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de SOLARA (66.7%) se considera alta.
Reducción de la deuda: SOLARAha pasado de 61.5% a 67.2% en los últimos 5 años.
Cobertura de la deuda: SOLARA's debt is not well covered by operating cash flow (15.3%).
Cobertura de intereses: Datos insuficientes para determinar si los pagos de intereses de SOLARA sobre su deuda están bien cubiertos por el EBIT.